human papillomavirus (HPV)
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:advocacy |
importance of regular health check-ups
awareness of HPV-related cancers education on HPV transmission support for HPV vaccination campaigns |
| gptkbp:cause |
gptkb:cervical_cancer
|
| gptkbp:clinical_trial |
ongoing for antiviral treatments
ongoing for new vaccines ongoing for therapeutic vaccines |
| gptkbp:community_health |
importance of vaccination
education on safe sex practices monitoring of HPV-related cancers screening and vaccination disparities exist screening programs recommended significant burden in developing countries |
| gptkbp:diagnosis |
HPV test
Pap smear |
| gptkbp:discovery |
identified in 1983
|
| gptkbp:diseases |
anal cancer
genital warts oropharyngeal cancer penile cancer |
| gptkbp:epidemiology |
common worldwide
most sexually active individuals infected at some point |
| gptkbp:genetic_diversity |
over 200 types identified
types 16 and 18 are high-risk types 6 and 11 are low-risk |
| https://www.w3.org/2000/01/rdf-schema#label |
human papillomavirus (HPV)
|
| gptkbp:infection_duration |
most clear within 2 years
persistent infections can lead to cancer |
| gptkbp:is_vulnerable_to |
gptkb:Cervarix
gptkb:Gardasil |
| gptkbp:prevention |
vaccination
regular screening |
| gptkbp:research |
ongoing studies on treatment
|
| gptkbp:risk_factor |
smoking
immunosuppression multiple sexual partners early sexual activity |
| gptkbp:seed_dispersal |
circular double-stranded DNA
|
| gptkbp:symptoms |
often asymptomatic
|
| gptkbp:transmission |
sexual contact
|
| gptkbp:treatment |
topical medications
laser therapy cryotherapy surgical removal of warts |
| gptkbp:type |
high-risk HPV types
low-risk HPV types |
| gptkbp:bfsParent |
gptkb:Cervical_Cancer_Vaccine_Initiative
|
| gptkbp:bfsLayer |
6
|